The BigMed project has received 60 million NOK in funding from the Research Council of Norway IKTPLUSS Lighthouse program. Jan Rasmus Sulebak (right side on picture, Erik Fosse left side) presented the winners at the eHEALTH 2016 event. For one year ago it was more than 70 interested parties to participate in the IKTPLUSS program, and finally only three were awarded funding.
The vision behind the BIG data MEDical solution (BIGMED) is to lay the foundation for an ICT platform that addresses the analytic bottlenecks for the implementation of precision medicine, and paves the way for novel big data analytics. The solutions will provide the patients with an optimized care which takes their unique individual characteristics into proper consideration.
We have selected four patient groups in focus in the project;patients with lung cancer, colorectal cancer, sudden cardiac death and monogenic diseases. The BigMed consortium includes patient organisations, academic- and industrial partners. Patient organiation partners are Kreftforeningen, Landsforeningen for hjerte- og lungesyke and Foreningen for hjertesyke barn. Industrial partners are DNV GL, Sykehuspartner HF, IBM World Trade Corporation, Pubgene AS, Kunnskapsforlaget ANS, DIPS ASA, Karolinska Institutet and Oslo Medtech NCE. Clinical partners are Oslo University Hospital (The Intervention Centre, Department of Oncology, Department of Molecular Pathology, Department of Medical Genetics, Department of Cardiology), Norwegian Armed Forces Joint Medical Service and Oslo Center for Biostatistics and Epidemiology. Academic partners from University of Oslo are Department of Informatics and The University Center for Information Technology. From NTNU Department of Computer and Information Science.
On April 12th 2016 the Norwegian Minister of Health Bent Høie visited The Intervention Centre. The Minister spent nearly two hours in the Operating Room area at the Centre and guided by professor Erik Fosse and CEO of the Oslo University Hospital Acute Clinic Øyvind Skraastad he watched three different ongoing minimally invasive procedures; laparoscopic pancreas surgery, MRI guided neuro-surgery and an endovascular aneurism repair (EVAR) procedure. In the picture radiologists and surgeons demonstrates aortic grafts used in invasive radiology procedures. See more @InterventionCen on Twitter.
Dr. Kyrre Eeg-Emblem, researcher at The Intervention Centre, has been awarded the Fridtjof Nansen award for young researchers for outstanding contributions in medical diagnostics from the Nansen Fund. The Fridtjof Nansen award is given to young researcher under 40 years with a permanent address in Norway. The price is 100.000 KOK and a diploma. The award is shared with Magne Mogstad. The award will be handed out at the general assembly of the Norwegian Academy of Science in the beginning of May 2016.
The Intervention Centre hosts part of a course for Gastroenterology
Surgeons at Oslo University Hospital in April 2016. Parts of the clinical
training will take place at the centre, and the program for the course
has been made available at The Intervention Centre web page. Se the
program here: Surgical Gastroenterology Course Program. The program contains downloadable articles and videos from many of the presenters.
On March 1st 2016 Stefan Hyler, MD defended his thesis on Microsensors allow continuous monitoring of myocardial ischemia in cardiac surgery at Institute of Clinical Medicine, University of Oslo. 1.opponent was Professor Anders Jeppsson,Thoraxkirurgisk avdeling,Sahlgrenska akademin, Gøteborgs Universitet, Sweden, 2.opponent: Overlege Ole Magnus Filseth, Akuttmedisinsk klinikk, Universitetssykehuset i Nord-Norge, 3. memember of committe: Førsteamanuensis Kristin Bjørnland, Institutt for klinisk medisin, Universitetet i Oslo, Norge. Image (from left): professor Anders Jeppson, main superviser Steinar Halvorsen MD, PhD, Ole Magnus Filseth MD, Stefan Hyler, MD, PhD and professor Erik Fosse, co-supervisor.
Three OUS researchers have been accepted as members: Gro Elisabeth Lind, head of the Epigentics group at the Department of Molecular Oncology at the Institute for Cancer Research, Kyrre Eeg Emplem, principal investigator in Atle Bjørnerud's Functional MR Neuroimaging group at the Intervention Centre and Monica Aas from Ingrid Melle's group at the Division of Mental Health & Addiction.
On September 16th 2015 Karl Øyri defended his thesis on Feasibility of short-range wireless monitoring in critical care environments. Background: Feasibility of patient monitoring in critical care based on short-range wireless technologies still is an open question. Despite wide penetration of the consumer market, short-range wireless technologies still are not widely implemented in clinical practice. Short-range wireless radio links, with air-based propagation of data, are more susceptible to electromagnetic interference than physically shielded wired links. Critical care settings with a high density of electronic medical devices represent a harsh environment for short-range wireless technologies. Since short-range wireless radios initially are not developed for medical use, clinical trials to study the robustness and stability of short-range wireless technologies in patient monitoring were the basis of this thesis. In critical care monitoring systems medical sensors sample data intermittently or as continuous data, and data streams are displayed on monitors as real-time waveforms or time-series of data. Announcement from Faculty of Medicine, University of Oslo here
Professor Erik Fosse, Head of The Intervention Centre, Oslo University Hospital, is awarded the University of Oslo Innovation Prize 2015. Prof.Fosse received the prize for his valuable contribution to the field of medicine and health services at a ceremony which took place September 2nd 2015. University of Oslo Innovation Prize short lectures here.
The Norwegian Research Council of Norway allocated funding for evaluation of the LuerJack®, single handed syringe concept, through the Regional Research, Design and Innovation (VRI) program. The Testbed at The Intervention Centre received an assignment from ConceptoMed to evaluate the clinical feasibility of the Luer Jack®. Focus group sessions with clinical specialists at Oslo University Hospital were conducted to gain feedback on the concept from potential users as well as to identify relevant user groups and clinical applications for further concept development. Results of the study show that the Luer Jack® may contribute to quality improvement of clinical procedures. The safety mechanism integrated to the device promotes an effective non-touch technique, potentially facilitating improved anti-septic and aseptic field management. The Luer Jack® as a safety syringe can reduce the risk of needle stick injury and health care acquired infection. The findings from the current study demonstrate the importance o user-centered design to mitigate risk and meet the challenges of healthcare services of the future. The Intervention Centre has established a Testbed for medical devices that serves as a platform where new early stage and pre-market diagnostic and therapeutic equipment and devices can be evaluated. The current project provides an example of successful collaboration between healthcare providers and companies developing new medical products and services. Demonstration of Luer Jack here
On April 30 2015 Kririll Neuman defended his thesis on Interventional Broncoscopy in Treatment of lung Cancer. Background: Interventional bronchoscopy is a field of respiratory medicine that is related to a broad range of diagnostic and therapeutic procedures done via bronchoscope. It includes, but is not limited to such procedures as laser bronchoscopy, electrosurgery, endobronchial ultrasound and needle aspiration, stent insertion, volume reduction procedures and many more. One can use a flexible or a rigid bronchoscope, and airway management during procedure can also vary a lot depending on the procedures art and aim. Extrinsic compression of the airways can for example be treated with stent insertion, whereas intraluminal tumors can be debulked mechanically, with electrocautery or laser ablation. A combination of different techniques is often used in practice to achieve the best result. A doctoral project on Interventional Bronchoscopy in Treatment of Lung Cancer by Kirill Neumann et al. of the Intervention Centre summarizes the institutional experience in interventional bronchoscopy since its introduction into clinical practice at the National Hospital of Norway in 1997. Announcement from Faculty of Medicine, University of Oslo here>>>
WiBEC (Wireless In-Body Environment Communications), an Innovative Training Network for 16 young researchers, has been selected for funding by the European Commission under the H2020- MARIE Sklodowska-CURIE ACTIONS (MSCA-ITN-2015). The beneficiaries are Oslo University Hospital (coordinator – professor Ilangko Balasingham), Norway, Sorin CRM, France, Universitat Politechnica de Valencia, Spain, Technische Universität Dresden, Germany, Ovesco AG, Germany, Norges tekninsk-naturvitenskapelige universitet, Norway, ValoTec, France, and Instituto de Investigación Sanitaria La Fe, Spain. The non-beneficiaries are Ecole Normale Supérieure de Cachan and Université Paris Sud, France. This training network will address the Social, Health, and Technology challenges of the H2020:Wireless In-Body Devices. WiBEC’s main objective is to provide high quality and innovative doctoral training to develop the wireless technologies for novel implantable devices for applications in cardiology and gastroenterology that will contribute to the improvement in quality and efficacy of healthcare.
On April 29 2015 Søren Erik Pischke defended his PhD thesis about Tissue PCO2 for real-time detection of internal organ ischemia. Main mentor was professor Tor Inge Tønnessen, and second mentor professor Tom Eirik Mollnes, both from Faculty of Medicine, University of Oslo.
Abstract: Stenosis or total occlusion of organ supplying vessels in the perioperative course of major surgery like heart surgery or liver transplantation leads to ischemic injury. Detection is challenging as no specific symptoms are revealed. Todays monitoring during anaesthesia and intensive care medicine relies on unspecific continuous observations of whole body circulation and intermittent evaluation by ultrasound and assessment of release of tissue enzymes to blood. Cellular metabolism gets altered during ischemia (severely hampered blood supply) and tissue CO2 is produced in the course of buffering anaerobic lactic acidosis. Image:Professor Tor Inge Tønnessen (left), Søren Erik Pischke, MD, PhD (middle), professor Tom Erik Mollnes (right).
IVS is well represented with a presentation from Professor
Ilangko Balasingham about automatic diagnosis using optical image processing,
while Jacob Bergsland and Espen Remme are in the program committee and are
chairmen for the sessions on welfare technology and robotics, respectively.
Additionally, there are sessions on:
-Big data – analysis, access and sharing of data
-Instrumentation, sensor technology and imaging
-Stavanger area relations, oil and medicine
Organizer is the Norwegian Society of Automatic Control. Link to program>>>
The PhD thesis work by Rahul Prasanna Kumar has resulted in the development of a method for 3D visualization of blood vessels that is nearly 20 times faster that many commonly used methods. Such fast methods are useful for many medical applications that involve diagnosis, therapy, and also in planning and navigation of surgeries.
Accurate and fast 3D visualization of blood vessels are important for liver surgery or resection. Liver resection can be performed by “formal resection”, or “parenchyma-sparing technique”. In the parenchyma-sparing technique, the surgery is performed such that only the region that has the cancer is removed, compared to formal resection that is the commonly used technique where the anatomical half of the liver that contains the tumor is removed. Thus, the parenchyma-sparing technique helps in saving a significant part of the patient’s liver, which increases the possibility of having multiple resections when cancer reemerges. However, this technique requires a thorough planning of the individual surgical strategy, i.e. an accurate visualization of the liver and its structures, especially the blood vessels. The method proposed in the thesis can help the surgeons in visualizing blood vessels for planning a liver surgery.
Visit the web page of the MedTech Test Facility at Oslo University Hospital. The Test Facility is a professional gateway for companies with new high tech equipment in need for early phase clinical trials.
English is the main language in this web portal. Some information is also available in Norwegian
The Interventional Centre receives donations to medical research. Questions related to donations can be sent to head of department professor Erik Fosse.
Author: Erik Fosse
Publisher: Det Medisinske Selskap 2007
Price: 180 kr
Also sold in Bookstores